INTRODUCTION

Top Abstract Introduction Materials & Methods Results Discussion References

In eukaryotic cells, all transport between the nuclear interior and the cytoplasm occurs through the nuclear pore complexes (NPCs) (reviewed in reference 16). According to the data that have accumulated during the last few years, proteins destined to enter the nucleus associate in the cytoplasm with receptors that recognize and bind specific sequences, termed nuclear localization signals (NLSs). These complexes are targeted to the NPC and are translocated into the nucleoplasm, where the import cargo is released and the receptor is recycled to the cytoplasm (reviewed in references 13, 31, 33, 65, and 68). In the case of the basic-type (classical) NLS, the receptor consists of importin  (karyopherin ), the NLS-binding component, and importin  (karyopherin ), which can interact with repeat-containing nucleoporins and is responsible for docking to the NPC. Importin  belongs to a large protein family whose members are characterized by the presence of an amino-terminally located Ran-GTP binding domain (23, 32). Other members of this family include transportin and Kap123p (Yrb4p), which respectively directly bind to some hnRNP proteins and ribosomal proteins, and mediate their nuclear import (24, 72, 79, 83, 96). Similar functions have also been proposed for their homologues Kap104p (1) and karyopherin 3 (105). Recently two more importin  homologues, Mtr10p and Sxm1p, have been shown to function as import receptors for Npl3p (a yeast hnRNP protein) and Lhp1p (the yeast La homologue), respectively (71, 78, 86).

The principles of active nuclear protein import may also apply to active nuclear export of proteins and RNA. Indeed, two members of the importin  family have been shown to be involved in nuclear export processes and were therefore termed exportins (reviewed in reference 102). Export of importin  from the nucleus is mediated by CAS (57), while CRM1 functions as an export receptor for the leucine-rich nuclear export signal (NES) (22, 26, 56, 67, 69, 98). This type of NES can mediate nuclear export of proteins or, as is the case for the human immunodeficiency virus protein Rev, of RNA-protein complexes (for a review, see reference 27). Export of U snRNAs, which requires the cap binding protein complex (50), has been suggested to follow the same route as export of Rev (19). Moreover, a NES-containing receptor has been implicated in the nuclear export of mRNA (70). The M9 domain of hnRNP A1 represents an additional type of NES (48, 62). hnRNP proteins shuttle between the nucleus and the cytoplasm and are required for mRNA export from the nucleus (65). Genetic screens in the yeast Saccharomyces cerevisiae have led to the identification of additional factors that are involved in mRNA nuclear export (2, 16, 54); among them, Nup159p (35), Mtr2p (53), Gle1p (64), Npl3p (60), Mex67p (85), and Dbp5p/Rat8p (97, 101) are candidates for proteins having a direct role in the mRNA export process.

A central role in the nucleocytoplasmic transport machinery is fulfilled by the small GTPase Ran and its effectors (30, 55, 63). Hydrolysis of GTP by Ran may provide the energy required for the translocation of transport complexes through the NPCs. However, recent data suggest that nuclear export of several substrates requires the presence of Ran-GTP in the nucleus (49, 77). Ran-GTP triggers the dissociation of the importin (karyopherin)-import substrate complex (34, 49, 76) while, on the other hand, promoting the association of an exportin with the corresponding export cargo (22, 57). According to these models, the abundance of the Ran-GTP form in the nucleoplasm may be due to the nuclear localization of the Ran nucleotide exchange factor RCC1 (Prp20p in yeast) and the nuclear exclusion of the GTPase-activating protein RanGAP1 (Rna1p in yeast). RanGAP1 and RanBP1 hydrolysis of the Ran-bound GTP may occur then only in the cytoplasm or close to the NPC and may represent the last step of an export reaction, the release of the export substrate. Although there is no evidence for the nucleotide-bound state of Ran in vivo, the in vitro results suggest that the directionality of the nuclear transport processes may be ensured by the distinct subcellular distribution of the components of the Ran system.

tRNA molecules are synthesized by RNA polymerase III as precursors which undergo a complex maturation pathway before they are exported from the nucleus. These sequencial events include trimming of the 5' and 3' ends, addition of three terminal CCA residues, modification of a number of nucleosides, and splicing (43). Export of tRNA from Xenopus oocyte nuclei was shown to be carrier mediated (106). Furthermore, structural integrity and maturation of the tRNA molecules are also required for efficient nuclear export (41, 100). For intron-containing pre-tRNAs, it has been suggested that the tRNA-splicing reaction may be coupled to the translocation step, since the key enzymes of splicing, the tRNA endonuclease and tRNA ligase, were found to be localized at the inner side of the nuclear membrane, in close proximity to the nuclear pores (103). It has been also shown that in yeast, several nucleoporin mutants are defective in pre-tRNA splicing as well as in biogenesis of active suppressor tRNA (87, 94), suggesting that pre-tRNA splicing and nuclear export of tRNA require functional nuclear pores. Furthermore, modification of tRNA appears to be also coupled to the nuclear export process (94).

Some aspects of nuclear export of tRNA differ from export of other RNA species. Microinjected tRNA in Xenopus oocyte nuclei is transported into the cytoplasm much faster than other RNA classes, and its nuclear export is not inhibited by homopolymeric RNAs, unlike the export of 5S RNA, mRNA, and U snRNAs (51). Export of tRNA is not affected by antibodies against the nucleoporin Nup98 or by the matrix protein of vesicular stomatitis virus, both of which impair export of other cellular RNAs (42, 73). Concerning the role of Ran in the export of tRNA, the available data are not consistent. While tRNA export was apparently not affected in a mammalian RCC1 mutant in which nuclear export of mRNA and snRNA was inhibited (12), it was recently reported that nuclear export of tRNA from oocyte nuclei requires the presence of Ran-GTP in the nucleus (49). Furthermore, the nuclear export of tRNA from oocyte nuclei can be significantly impaired by injection of dominant-negative importin  mutants (58). Therefore, the tRNA export mechanism may be similar, at least in part, to the mechanisms regulating nuclear export of proteins or other RNAs.

The LOS1 gene was originally identified as a mutant exhibiting a conditional loss of tRNA^Tyr suppressor activity (44). los1 mutants produce reduced levels of functional suppressor tRNAs and accumulate end-trimmed, but unspliced, pre-tRNA, although they apparently contain normal levels of tRNA splicing endonuclease and ligase activities (45, 88, 89). We have recently shown that a significant pool of Los1p is localized at the nuclear pores and that Los1p genetically interacts with the nuclear pore protein Nsp1p as well as with components required for tRNA biogenesis, such as Pus1p, a nuclear tRNA pseudouridine synthase; Tfc4p, a subunit of the tRNA transcription factor TFIIIC; and Arc1p, a cytoplasmic protein that delivers at least two tRNA species to the corresponding aminoacyl-tRNA synthetases (92-94). These data suggested a close relationship between tRNA processing and tRNA transport and indicated that Los1p might be required for the nuclear export step of tRNA biogenesis. Sequence homology searches have shown that Los1p contains an amino-terminal Ran-GTP binding motif that characterizes the importin  protein family (32). In addition, two groups have recently reported the cloning and characterization of a mammalian member of the importin  protein family that can function as an exportin for tRNA (3, 59). This protein also displays significant sequence homology to yeast Los1p.

To gain further insight into the function of Los1p in yeast, we used the two-hybrid system to search for proteins that physically interact with it. The results of this analysis, as well as biochemical data, show that Los1p binds to nucleoporins and to the GTP-bound form of Gsp1p, the yeast Ran. Furthermore, the formation of the Los1p-Gsp1-GTP complex is stimulated in the presence of tRNA, as revealed in an indirect in vitro binding assay. Thus, Los1p appears to be a nuclear export factor for tRNA.

	MATERIALS AND METHODS

Top Abstract Introduction Materials & Methods Results Discussion References

Yeast strains, media, and plasmids. The yeast strains used in this work are listed in Table 1. Cells were grown in rich yeast-peptone-dextrose medium or in synthetic dextrose complete medium containing the necessary amino acids and nutrients. For counterselection of URA3- or CYH2-containing plasmids, 5-fluoroorotic acid (5-FOA; Toronto Research Chemicals) or cycloheximide (Sigma) was used, respectively. Test plates for the two-hybrid system contained SDC-Trp-Leu-His plus 100 mM NaP_i (pH 7.0), 15 to 25 mM 3-aminotriazole (3AT; Sigma), and 65 mg of 5-bromo-4-chloro-3-indolyl--D-glucuronic acid (X-Gal; Biomol) per liter. Yeast cells were transformed by the lithium acetate method (80). Genetic manipulations, including mating, sporulation, and tetrad dissection of yeasts, were performed as described elsewhere (90). The following yeast plasmids were used: pUN100 (17), pRS313 (91), pRS316 (91), YCplac111 (29), pAS2(pAS1-CYH2) (40), and pACTII (40). YEp13-GAL10-CYC1 was constructed by inserting the GAL10-CYC1 hybrid yeast promoter, cut as an EcoRV-BamHI fragment from vector pLGSD5 (39), between the unique PvuII and BamHI sites of YEp13. Plasmid pEMBLyex4-ATG was constructed as follows: the sequence between the XhoI and BamHI sites of plasmid pEMBLyex4 (11), containing the CYC1 promoter, was replaced by the corresponding sequence of plasmid YEp13-GAL10-CYC1, which contains the CYC1 promoter followed by an ATG start codon.

Two-hybrid screen. Cells of Y190(pAS2-LOS1) (100 ml; see below) grown in SDC-Trp to an optical density at 600 nm (OD₆₀₀) of 1.0 were transformed with 50 µg of library DNA. With the help of glass beads, transformants were spread on four plates (25 cm by 25 cm) of SDC-Trp-Leu-His plus 25 mM 3AT that had been covered with nitrocellulose filters; the plates were then incubated for 7 days at 30°C, and the resultant colonies were then transferred to SDC-Trp-Leu-His plus 25 mM 3AT and X-Gal and incubated for 3 days at 30°C. The theoretical number of transformants was calculated by plating an aliquot of the cell suspension on SDC-Trp-Leu. In the first screen, an S. cerevisiae cDNA library in pACT (40) yielded 3.0 × 10⁶ transformants, of which 18 colonies grew and turned blue on the test plates. In a second screen, an S. cerevisiae genomic library in pACTIIStopBis (25) yielded 6.4 × 10⁶ transformants, of which 25 were positive. Blue colonies were restreaked on SDC-Leu (additionally containing 2.5 mg of cyclohexamide per ml to select against the CYH2 marker on the pAS2 plasmid) and on SDC-Trp (the loss of the pACTII plasmid was verified by restreaking on SDC-Trp-Leu). Plasmids from those colonies which no longer showed -galactosidase activity on X-Gal-containing plates were recovered by glass bead lysis and transformation of Escherichia coli MC1061. Y190(pAS2-LOS1) was retransformed with the recovered plasmid DNA and again tested for -galactosidase activity. Two and 15 clones from the first and second screens, respectively, passed all false-positivity tests.

Two-hybrid interaction assay. The DNA fragments of interest were PCR amplified, using genomic copies of LOS1 and NUP2 in plasmids pUN100-LOS1 (94) and pJON37 (61) as the template, respectively. The GSP1 open reading frame (ORF) was amplified from genomic DNA, while the GSP2 ORF was amplified from pUN100-GSP2 (55a). The PCR products were cut with NcoI and BamHI, ligated into the GAL4 DNA binding domain vector pAS2, and then subcloned into the GAL4 activation domain vector pACTII. Yeast strain Y190 was transformed with each of these plasmids, and expression of the resulting Gal4p-hemagglutinin fusion proteins was checked by Western blotting with the monoclonal mouse antibody 12CA5, produced against the hemagglutinin epitope tag. Colonies that contained both bait and prey plasmids were tested on SDC-Trp-Leu-His plus 15 mM 3AT and X-Gal. Development of a blue color was scored after 3 to 4 days. To quantify the -galactosidase activity, an o-nitrophenyl--D-galactopyranoside (ONPG) liquid assay was used. Briefly, the yeast cells in 0.5 to 1 ml of a liquid culture in SDC-Trp-Leu at an OD₆₀₀ of 0.5 to 1 were harvested by centrifugation, incubated in 500 µl of Z buffer (100 mM NaP_i [pH 7.2], 10 mM KCl, 1 mM MgSO₄) with 0.36% -mercaptoethanol, permeabilized with 200 µl of water-saturated diethyl ether, and incubated with 100 µl of a 4-mg/ml solution of ONPG (Sigma). The reaction was stopped by addition of 250 µl of 1 M Na₂CO₃. The activity (per milliliter per minute) was calculated with the equation 1,000 × (OD₄₂₀/OD₆₀₀ × V × t), where V is culture volume and t is reaction time.

Mutation of genes and construction of shuffle strains. The GCD11 gene was cloned into pRS316 as a HindIII-EcoRI fragment from pUN100 GCD11, which contains a 2.1-kb PCR-amplified HindIII-SnaBI fragment, using genomic DNA as a template. For disruption of the whole GCD11 ORF, a direct gene deletion method was used (4). A heterozygous diploid (RS453 derivative) harboring the correct gcd11::HIS3 disruption at the GCD11 gene locus was verified by PCR. The positive strain (YKH44) was sporulated. A 2:2 segregation pattern for cell growth was observed in a tetrad analysis. To construct a GCD11 shuffle strain, YKH44 was transformed with pRS316-GCD11 and sporulated. A His⁺ Ura⁺ FOA spore (YKH45) of a 4:0 tetrad was chosen as the shuffle strain. This strain was mated to Y547 (los1::HIS3) in order to obtain YKH53 (los1::HIS3 gcd11::HIS3) containing pRS316-GCD11, which was then transformed with the plasmids Ep552 (pSB32-GCD11), Ep653 (pSB32 gcd11-G397A), Ep620 (pSB32 gcd11-R510H), and Ep654 (pSB32 Ty525), which were kindly provided by E. Hannig (15). The GSP1 gene was excised from plasmid YEp352-GSP1 (5) as a 3.2-kb SalI-SacI fragment and ligated into pRS316. To construct a GSP1 shuffle strain, the heterozygous diploid strain YMO106 harboring a gsp1::HIS3 disruption (52) was transformed with pRS316-GSP1 and sporulated. A His⁺ Ura⁺ FOA spore (YKH64) of a 4:0 tetrad was chosen as the shuffle strain. The gsp1::HIS3 disruption in YKH64 was verified by PCR. A GAL1-driven version of GSP1(G21V) was constructed based on plasmid pGPCNR1 (52), which contains a wild-type GSP1 BamHI-HindIII fragment. A version of this fragment coding for Gsp1(G21V) was generated by a two-step PCR procedure (28) (mutagenizing primer, 5'-CTTACCAGTACCAACATCACCGACAAG-3') and inserted into the corresponding sites in YEp352GAL (6). The mutation was verified by nucleotide sequence analysis.

Construction and affinity purification of fusion proteins. A DNA fragment coding for two immunoglobulin G (IgG) binding domains of protein A (ProtA), under the control of the NOP1 promoter, followed by a TEV proteolytic cleavage site (ENLYEQG) was fused to the 5' end of the LOS1 gene, yielding plasmid pUN100-NOP1::ProtA-TEV-LOS1, as will be described elsewhere (41a). The ORF of GSP1 or the GSP1-G21V mutant version was PCR amplified from YEpCNR1 (52) or YEp352GAL-GSP1-G21V, respectively, and was used to generate pUN100-NOP1::ProtA-TEV-GSP1::ADH1(terminator) and pUN100-NOP1::ProtA-TEV-GSP1-G21V::ADH1(terminator). The GSP1 shuffle strain was transformed with one of these plasmids and tested for growth on SDC-FOA. Affinity purification by IgG-Sepharose chromatography was done as described earlier (95), with modifications, and elution from the IgG-Sepharose column was performed with recombinant TEV protease. Typically, 10 g of spheroplasts was lysed in 50 ml of a lysis buffer containing 150 potassium acetate, 20 mH HEPES-KOH (pH 7.0), 2 mM magnesium acetate 0.1% Tween 20, and a cocktail of protease inhibitors (Boehringer Mannheim). The crude cell extract was then centrifuged at 25,000 × g for 10 min at 4°C. The supernatant was applied onto a column packed with 250 µl of IgG-Sepharose beads (Pharmacia). The beads were extensively washed with lysis buffer and equilibrated with 1 ml of a cleavage buffer containing 150 mM potassium acetate, 20 mH HEPES-KOH (pH 7.0), 0.5 mM EDTA, and 1 mM dithiothreitol and transferred onto a spin column (MoBiTec). One volume of beads was mixed with one volume of cleavage buffer, and 100 U of TEV protease was added. The mixture was incubated for 2 h at 16°C on a rotating wheel prior to removal of the eluate by a short centrifugation. The elution was completed with an additional bed volume of cleavage buffer.

Overexpression of LOS1. To construct an amino-terminal truncation of Los1p, a fragment of LOS1 (codons 195 to 425) was PCR amplified, cut with PstI and XbaI, and ligated to a BamHI-PstI NOP1::ProtA cassette and an XbaI-BamHI fragment of pUN100-LOS1, which contained the rest of the LOS1 gene. The coding sequences for ProtA-Los1p and ProtA-Los1Np were removed as SphI fragments from the vectors pUN100-NOP1::ProtA-LOS1 and pUN100-NOP1::ProtA-LOS1N, respectively, blunt ended, and inserted downstream of the strong and inducible GAL10-CYC1 hybrid promoter of BamHI-cut and blunt-ended YEp13-GAL10-CYC1, creating plasmids YEp13-GAL-ProtA-LOS1 and YEp13-GAL-ProtA-LOS1N, respectively. Wild-type yeast cells carrying these plasmids were allowed to grow in raffinose-containing medium before induction by dilution in medium containing 2% galactose. To obtain higher levels of LOS1 expression, the coding sequences for ProtA-Los1p and ProtA-Los1Np were also individually subcloned as BamHI fragments into vector pEMBLyex4-ATG. This vector contains as a selectable markers URA3 and the poorly expressed leu2-d allele of LEU2, which increases the copy number of the plasmid under leucine selection conditions (14).

Green fluorescent protein (GFP) tagging and localization of proteins. pRS314 carrying an in-frame YRB1-GFP(S65T) fusion was constructed by introducing a unique BamHI site before the translation termination codon of a chromosomal EcoRI-XbaI YRB1 fragment on pRS314 by a single-step PCR. Insertion of a BamHI-GFP(S65T) cassette (85) into this BamHI site yielded plasmid pRS314-YRB1-GFP(S65T). Tagging of MEX67 and NPL3 with GFP was described previously (85, 86). The plasmid expressing NLS-GFP-lacZ was kindly provided by G. Schlenstedt, and the plasmid expressing GFP-NOP1 was provided by B. Senger. Amino-terminal tagging of Pus1p with GFP was done by subcloning the PUS1 ORF as a PstI fragment, cut from pUN100-ProtA-PUS1 (94), into pRS315 containing the NOP1::GFP cassette (41a). All GFP-tagged proteins were functional because they could complement the corresponding mutant yeast strains (data not shown).

Purification of E. coli recombinant proteins. The cloning of the LOS1 and MTR10 ORFs into the E. coli expression vector pET8c has been described previously (86, 94). To produce only the amino-terminal part of Los1p (amino acids 1 to 563), the ORF downstream of the internal SpeI site was deleted by cutting pET-LOS1 with SpeI-MluI and inserting at the blunt-ended sites a palindromic 29-mer oligonucleotide that contains stop codons in all six frames and a BamHI site in the middle. The vectors containing the fusion genes were transformed into E. coli BL21 cells. Cultures (500 ml each) were grown in minimal medium at 37°C to an OD₆₀₀ of 0.7, shifted to 25°C, and induced by addition of 0.1 mM isopropyl--D-thiogalactopyranoside (IPTG). The bacterial cell pellet was lysed by sonication in 10 ml of a solution containing 50 mM Tris-Cl, 100 mM NaCl, 10 mM MgCl₂, 5% glycerol, and 5 mM -mercaptoethanol (pH 7.5). The lysate was cleared by ultracentrifugation (Beckman SW40 rotor, 35,000 rpm, 45 min) and applied onto a nickel-nitrilotriacetic acid (Ni-NTA) resin (QIAGEN, Hilden, Germany) column. Bound proteins were eluted with 200 mM imidazole in lysis buffer and, when necessary, dialyzed against a solution consisting of 20 mM Tris-Cl, 100 mM NaCl, and 1 mM dithiothreitol (pH 7.4). Los1p and Mtr10p were further purified by chromatography on a Mono Q HR 5/5 column (Pharmacia) equilibrated in the same buffer and eluted with an NaCl gradient. The expression and purification of Rna1p and Kap95p were done as described previously (9, 34). The concentrations of the recombinant proteins in partially purified preparations were determined by comparing the intensities of the Coomassie-stained bands and using bovine serum albumin as a marker.

Enzymatic Gsp1p-GTP binding assays. GTPase assays were carried out as described elsewhere (8, 10, 83). Briefly, 50 pM Gsp1p-[-³²P]GTP was incubated in a 50-µl volume with the corresponding Gsp1p-binding protein in incubation buffer. The GTPase reaction was started by addition of 20 nM Rna1p. After a 2-min incubation at 25°C, released [³²P]phosphate was determined by the charcoal assay (8). Total yeast tRNA and tRNA^Phe (Sigma) were used after purification by phenol extraction and ethanol precipitation. 5S rRNA was from Boehringer Mannheim.

Antibodies. The following antisera were used in this study: anti-Nsp1p (EC9-1), which cross-reacts with FXFG repeat-containing nucleoporins like Nup1p and Nup2p and was originally raised against an insoluble nuclear fraction (46); anti-Los1p, which was raised against the His₆-tagged protein produced in E. coli (94); and anti-Gsp1p, which was a gift of J. Becker (MPI für Molekulare Physiologie, Dortmund, Germany). The preparation of a rabbit polyclonal anti-Yrb1p antiserum will be described elsewhere (56a).

	RESULTS

Top Abstract Introduction Materials & Methods Results Discussion References

Nup2p and Gcd11p were found in a two-hybrid screen with Los1p as the bait. To identify possible binding partners of Los1p, we utilized the two-hybrid system, with full-length LOS1 (attached to the GAL4 DNA binding domain) as the bait. After transformation with a yeast cDNA library fused to the GAL4 activation domain, two clones that showed activation of both reporter genes, HIS3 and lacZ, and passed all false-positivity tests were isolated (see Materials and Methods). Sequence analysis of the inserts revealed that both corresponded to GCD11. In a second screen, using another yeast genomic library, positive clones which contained genomic inserts encoding GCD11 or NUP2 were isolated. The inserts isolated in the screen correspond to the amino-terminal region of Nup2p (amino acids 42 to 177) or three fragments of the carboxy-terminal part of eIF-2 (amino acids 320 to 527, 329 to 527, and 368 to 527), which is encoded by GCD11. eIF-2 is the  subunit of the eukaryotic protein translation initiation factor 2, which is responsible for binding to the charged initiator tRNA^Met and delivering it to the small ribosomal subunit. Nup2p, like Nsp1p and Nup1p, is a nuclear pore protein containing FXFG-type repeat sequences. The two-hybrid interactions were specific since only the combination of the LOS1 bait plasmid with the GCD11 or the NUP2 prey plasmid allowed growth and development of a blue color on the test plates (Fig. 1 and Table 2). Neither LOS1, GCD11, nor NUP2 alone activated transcription of the reporter genes; additionally, GCD11 or NUP2 in combination with an irrelevant bait plasmid did not activate transcription of these genes.

View larger version (53K): [in this window] [in a new window]   FIG. 1.   Two-hybrid interactions of Los1p. Los1p interacts with Gcd11p (A) and Nup2p (B). The yeast screening strain Y190 was transformed with the indicated bait (pAS2) and prey (pACTII) plasmids in various combinations, and in each case two independent transformants were tested for growth (His+) and -galactosidase activity (LacZ+) on plates of SDC-Trp-Leu-His plus 3AT and X-Gal. Only in the presence of both pAS2-LOS1 as bait and pACTII-GCD11C (codons 368 to 527) or pACTII-NUP2N (codons 42 to 177) as prey were blue-colored yeast cells found growing on selective plates. The bait plasmids pAS1-SNF1 (40) and pAS2-NSP1M (codons 273 to 564 of NSP1) (3a) served as negative controls.

GCD11 genetically interacts with LOS1. The interaction between Los1p and the carboxy-terminal part of eIF-2 in the two-hybrid system was unexpected. To find out whether these two proteins also functionally interact, we checked for a synthetic-lethal relationship. Various mutations in GCD11, the gene coding for the yeast translation initiation factor subunit eIF-2, have been described previously (15). While four of these mutants show severe growth defects and were therefore not suitable for the plasmid shuffling assay, three of the mutants map in the carboxy-terminal region of Gcd11p and grow well under permissive conditions. These alleles, gcd11-G397A and gcd11-R510H, which contain point mutations in codons 397 and 510, respectively, and gcd11-508, which contains a Ty insertion after the second-to-last codon, 525 (and therefore is referred to here as gcd11-Ty525), were combined with a los1::HIS3 disruption. While the wild-type control and the Ty insertion mutant still grew at normal levels in the absence of Los1p, both point mutants failed to grow in a los1 background (Fig. 2, left). This synthetic-lethal phenotype is specific, since the nongrowing strains could be rescued by cotransformation with a single-copy plasmid that contains the LOS1 wild-type gene (Fig. 2, right). This is indicative of a genetic interaction between Los1p and the carboxy-terminal region of Gcd11p, which is reported to be part of the tRNA binding domain and which also interacts with Los1p in the two-hybrid system (see also discussion).

View larger version (47K): [in this window] [in a new window]   FIG. 2.   Genetic interaction between LOS1 and GCD11. Shuffle strain YKH53 (los1::HIS3 gcd11::HIS3) containing pRS316-GCD11 was transformed with various GCD11 alleles on a LEU2 plasmid and then streaked on 5-FOA-containing medium, on which cells with the URA3 plasmid, which contains the GCD11 wild-type gene, were selected against. The GCD11 point mutations G397A and R510H, combined with a los1::HIS3 disruption, led to synthetic lethality (left), which was overcome by cotransformation with a LOS1 wild-type gene on a TRP1 plasmid (right).

Nsp1p, Nup2p, and Gsp1p-GTP associate with Los1p. To confirm the interaction between Los1p and nucleoporins such as Nup2p in an independent way, Los1p was purified from yeast by affinity chromatography and analyzed for copurifying components. For this purpose, full-length Los1p was amino-terminally tagged with two IgG-binding domains of Staphylococcus aureus protein A followed by a proteolytic cleavage site for the TEV protease. The ProtA-TEV-LOS1 construct was able to complement the thermosensitive Los1 Pus1 double mutant and the synthetic-lethal Los1 Arc1 double mutant and thus was functional (data not shown). Furthermore, to test whether the GTP-bound form of Gsp1p would affect association of Los1p with other cellular proteins, the ProtA-TEV-Los1p-producing strain was cotransformed with a plasmid that expresses the mutant form Gsp1p-G21V. This mutation (a substitution of glycine for valine at position 21) stabilizes the GTP-bound form of Gsp1p and inhibits both nuclear protein import and mRNA export (82). For these experiments, the GSP1-G21V gene was controlled by the galactose-inducible GAL promoter. We prepared extracts from cells that do not produce the mutant form of Gsp1p, by growing them in glucose, and from cells in which the expression of the dominant-negative mutant GSP1-G21V was induced, by shifting the cells from glucose to galactose medium for 7 h. Each extract was passed through an IgG-Sepharose column, and the bound proteins were eluted by incubation with the TEV protease. Analysis of the eluates by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and protein staining showed some weaker bands, in addition to the 125-kDa band that corresponds to Los1p, but did not reveal major differences between the two eluates (Fig. 3A, lanes 3 and 4). Furthermore, none of the major visible bands were specific for the Los1p purification, since they could also be observed when a control protein (ProtA-TEV-DHFR, with the last component being mouse dihydrofolate reductase) was purified under the same conditions (data not shown).

View larger version (51K): [in this window] [in a new window]   FIG. 3.   Affinity purification of Los1p and Gsp1p. (A) Cells expressing ProtA-TEV-LOS1 and carrying the plasmid YEp352GAL-GSP1-G21V were grown in the absence () or presence (+) of galactose. After lysis, the soluble proteins (supernatants [Sup]) were passed over an IgG-Sepharose column, to which ProtA-TEV-Los1p and associated proteins bound. Los1p was then eluted from the column by incubation with recombinant TEV protease, which cleaves and removes the protein A tag. Supernatants and eluates (Elu) were analyzed by SDS-PAGE and Coomassie staining (lanes 1 to 4) or by Western blotting with the indicated antibodies (lanes 5 to 16). The eluates were shown to contain Los1p, Gsp1p, Nsp1p, and Nup2p. The amount of Gsp1p in the eluate was increased when the cells were grown in the presence of galactose and, therefore, expressed the GSP1-G21V mutant form. (B) Soluble proteins (supernatants) derived from cells expressing ProtA-TEV-DHFR (lanes 1 and 3) or ProtA-TEV-LOS1 (lanes 2 and 4) were applied onto an IgG-Sepharose column, and bound proteins were eluted by treatment with TEV protease. The material loaded on the column (Sup) and the eluates (Elu) were analyzed by Western blotting with anti-Nsp1p antibodies. In the two soluble-protein preparations (lanes 1 and 2), the antibody recognized, in addition to Nup2p and Nsp1p, the protein A tag of Los1p and DHFR. Note that Nup2p and Nsp1p specifically copurified with Los1p and were present in the eluate derived from the ProtA-TEV-Los1p-expressing cells (lane 4) but absent from the eluate from Prot-TEV-DHFR-expressing cells (lane 3). (C) Soluble extracts derived from cells expressing ProtA-TEV-GSP1 (lanes 1 and 2) or ProtA-TEV-GSP1-G21V (lanes 3 and 4) were passed through an IgG-Sepharose column, and bound proteins were eluted by TEV-mediated proteolytic cleavage. The SDS-PAGE-separated extracts (Sup) and the eluates (Elu) were probed with anti-Los1p, anti-Yrb1p, and anti-Gsp1p antibodies. Only the relevant parts of the blots are shown. In the extracts (lanes 1 and 3), equal amounts of Los1p, Yrb1p, and chromosomally encoded Gsp1p were evident. The eluate derived from ProtA-TEV-GSP1-expressing cells contained only Gsp1p (lane 2), while the eluate derived from ProtA-TEV-GSP1-G21V-expressing cells contained, besides Gsp1p-G21V (which migrates slower than native Gsp1p, due to the small amino-terminal addition present after TEV cleavage), also Los1p and Yrb1p (lane 4).

Overexpression of LOS1 impairs nuclear export. The binding of Los1p to Gsp1-GTP and its association with the nuclear pore complexes indicate that Los1p participates in nuclear transport processes. However, a disruption mutant of LOS1 was viable and was not impaired in nuclear import of NLS reporter proteins or in nuclear mRNA export (94). Therefore, we tested whether overproduction of Los1p or a truncated form, Los1Np, that lacks the amino-terminal 194 amino acids comprising the putative Ran-GTP binding domain can cause a dominant-negative phenotype with regard to nuclear transport mechanisms. Expression of both ProtA-LOS1 and ProtA-LOS1N, driven from a YEp13 high-copy-number plasmid and the GAL10 promoter in the presence of galactose, was approximately fivefold higher than expression from a centromeric plasmid and a constitutive promoter (Fig. 4A, compare lanes 1 and 2 with 3 and 4). This overexpression led to a reduction of cell growth (Fig. 4B, upper panel). On the other hand, the colony sizes of these strains on plates were very heterogeneous, suggesting differing levels of expression of Los1p due to different plasmid copy numbers in individual cells. To overcome this problem, ProtA-LOS1 and ProtA-LOS1N were subcloned in a modified pEMBLyex4 plasmid, which ensures very high and controlled copy numbers in all cells under selective conditions (see Materials and Methods). These constructs were transformed in wild-type cells, and overexpression was induced by adding galactose to cultures pregrown in raffinose medium. Under these conditions, ProtA-Los1p or ProtA-Los1Np production, which was further increased by a factor of 2 to 3 (Fig. 4A, lane 5 and 6), now caused a complete inhibition of growth in liquid cultures (Fig. 4B, lower panel) and on plates (data not shown). Thus, overproduction of full-length or truncated Los1p causes a dominant-negative growth defect.

View larger version (21K): [in this window] [in a new window]   FIG. 4.   Inhibition of cell growth by overexpression of LOS1. (A) Total lysates of cells grown for 4 h in the presence of galactose were analyzed by SDS-PAGE and Coomassie staining (upper panel) or Western blotting (lower panel) to determine the level of the protein A-tagged proteins. The cells were carrying the following plasmids: lane 1, pUN100-ProtA-LOS1; lane 2, pUN100-ProtA-LOS1N; lane 3, YEp13-GAL-ProtA-LOS1; lane 4, YEp13-GAL-ProtA-LOS1N; lane 5, pEMBLyex4-ProtA-LOS1; and lane 6, pEMBLyex4-ProtA-LOS1N. The positions of molecular mass markers (10-kDa ladder) are indicated by the bars on the left (highest bar, 200 kDa; next bars, 120, 110, and 100 kDa; etc.) (B) Wild-type cells transformed with YEp13 (upper panel) or pEMBLyex4 (lower panel) containing no inserts () or carrying ProtA-LOS1 () or the truncation mutant ProtA-LOS1N () under the control of the GAL10-CYC1 inducible promoter were grown in raffinose-containing medium. At time zero, expression was induced by diluting the cultures in medium containing 2% galactose. Growth rates were determined by monitoring the OD600.

ProtA-LOS1N

LOS1N

View larger version (101K): [in this window] [in a new window]   FIG. 5.   Inhibition of nuclear transport processes by overexpression of LOS1. (A) Cells containing pEMBlyex4 (GAL), pEMBLyex4-ProtA-LOS1 (GAL-LOS1), or pEMBLyex4-ProtA-LOS1N (GAL-LOS1N) and expressing GFP-PUS1, GFP-NPL3, or GFP-NOP1, as indicated, were grown in the presence of galactose for 7 h. The intracellular location of the GFP-tagged proteins was revealed by fluorescence microscopy. (B) Cells carrying pEMBlyex4 (GAL), pEMBLyex4-ProtA-LOS1 (GAL-LOS1), or pEMBLyex4-ProtA-LOS1N (GAL-LOS1N) were grown in galactose medium for 3 h and then processed for in situ localization of mRNA and stained for DNA with 4',6-diamidino-2-phenylindole (DAPI). (C) Mex67 cells expressing MEX67-GFP were transformed with pEMBLyex4 (GAL), pEMBLyex4-ProtA-LOS1 (GAL-LOS1), or pEMBLyex4-ProtA-LOS1N (GAL-LOS1N) (upper two rows), and wild-type cells expressing YRB1-GFP were transformed with YEp13-GAL (GAL), YEp13-GAL-ProtA-LOS1 (GAL-LOS1), or YEp13-GAL-ProtA-LOS1N (GAL-LOS1N) (lower two rows). After growth in galactose medium for 7 h, the localization of the GFP-tagged proteins was observed. Nom., Nomarski image.

ProtA-LOS1N

LOS1N

LOS1N

LOS1N

LOS1N

Los1p interacts with Gsp1p-GTP in vitro only in the presence of tRNA. Since Los1p was found to bind preferentially to the GTP-bound form of Gsp1p (see above), we wished to characterize this interaction in more detail. Since binding of an importin--related protein to Ran-GTP is reflected by its ability to inhibit the exchange and hydrolysis of bound GTP (7, 21, 34), this interaction can be used to estimate the dissociation constants of the resulting complexes. For this purpose, we expressed and isolated the following proteins from E. coli: recombinant Los1p; its amino-terminal domain (Los1Np, amino acids 1 to 563), which is expected to contain the Ran-GTP binding site; and, as controls, Mtr10p and Kap95p (yeast importin ). The results of the protein composition analysis of the Los1p, Mtr10p, and Los1Np preparations are shown in Fig. 6A. Both highly and partially purified samples were used, without any difference in the results since contaminating E. coli proteins, present also in the control samples, did not affect the assay. When Los1p- or Los1Np-containing preparations were incubated with Gsp1p loaded with GTP, no inhibition of GTP exchange (data not shown) or Rna1p-induced hydrolysis of Gsp1p-bound GTP (Fig. 6B) could be observed, even at micromolar concentrations of the respective Los1p construct. However, under the same conditions, recombinant yeast importin  (Kap95p) and importin--related Mtr10p, which were used as controls, inhibited GTP hydrolysis at concentrations corresponding to the previously reported affinities (Fig. 6C). A similarly weak binding to Ran-GTP has previously been shown for CAS, the nuclear export receptor for importin  (57). The affinity of CAS for Ran-GTP is very low but is substantially increased in the presence of the export cargo. We therefore assumed that Los1p could be a nuclear export factor and hence included in the Ran-binding assay, in addition to recombinant Los1p, potential candidates for export cargos, such as tRNA or Arc1p and Pus1p, two tRNA binding proteins that genetically interact with Los1p.

View larger version (20K): [in this window] [in a new window]   FIG. 6.   Interaction of recombinant Los1p with Gsp1p-GTP and tRNA. (A) His6-tagged Los1p-, Mtr10p-, and Los1Np-containing E. coli lysates were passed through a Ni-NTA-agarose column, and bound proteins were eluted with 200 mM imidazole, desalted, concentrated, and analyzed by SDS-PAGE and Coomassie staining (lanes 2 to 4). In the case of Los1p and Mtr10p, Ni-NTA column eluates were subsequently passed through an ion-exchange column (Mono Q) and bound proteins were eluted with an NaCl gradient. The fractions containing Los1p or Mtr10p were pooled, desalted, concentrated, and analyzed by SDS-PAGE and Coomassie staining (lanes 5 and 6). Minor bands in these preparations represented mostly degradation products. From top to bottom, arrowheads indicate the positions of Los1p, Mtr10p, and Los1Np, respectively. Lane 1 contains molecular mass standards (M; 10-kDa ladder; the most intense band corresponds to 50 kDa). (B and C) Cooperative binding of Gsp1p-GTP and tRNA to Los1p. Gsp1p-[-32P]GTP (50 pM) was preincubated for 15 min either with the importin--related proteins alone, with these proteins as mixtures with tRNA or 5S rRNA in the indicated concentrations, or with incubation buffer. Then 20 nM Rna1p was added, and the reaction was allowed to proceed for 2 min. Where indicated, Yrb1p was added immediately before the addition of Rna1p. Hydrolysis of Gsp1p-bound GTP was determined as released [32P]phosphate.

	DISCUSSION

Top Abstract Introduction Materials & Methods Results Discussion References

Los1p is required for suppressor tRNA activity in yeast; it is genetically linked to different tRNA binding and modification enzymes, and it is associated with the nuclear pore complexes and physically interacts in vivo with Nsp1p, Nup2p, and Ran-GTP. Furthermore, Los1p can form a complex with Ran-GTP and tRNA, as detected in vitro by an established indirect binding assay (86). Taken together, these results provide experimental evidence that yeast Los1p is indeed a bona fide member of the importin--like family, with a possible role in nuclear export of tRNA. Human LOS1, which shows a distinct sequence homology to yeast Los1p, has already been shown to act as a tRNA exportin in higher-eukaryotic cells (3, 59).

Formation of a complex between Los1p, Ran-GTP, and tRNA has so far been observed only in an indirect in vitro assay. By biochemical purification, we were not able to obtain sufficient amounts of a Los1p-tRNA complex in the presence of Ran-GTP (41a). The reason for this difference is not clear, but it could be due to the fact that a trimeric Los1p-Gsp1p-GTP-tRNA complex is kinetically unstable and therefore dissociates when the excess free components are removed in the necessary washing steps preceding biochemical isolation. Indeed, we have experimental evidence that the Los1p-Gsp1p-GTP-tRNA complex is very short-lived (half-life, 7 min) in the indirect binding assay compared to the corresponding complexes of importin  or transportin and Ran-GTP (half-lives, 2 to 4 hours [7]).

It appears relevant, in this respect, that Los1p is genetically linked to the intranuclear tRNA modification enzyme Pus1p (94). Pus1p catalyzes the formation of pseudouridine in several tRNAs, at positions which are specific for the eukaryotic cell. Therefore, it is possible that these modifications act as positive determinants for association of tRNA with the nuclear export machinery and in particular with Los1p. In support of this, the human homologue of Los1p was shown to bind stronger to native tRNA than to tRNA that was produced in vitro and therefore lacked all modifications (59).

After assembly in the nucleus, a putative Los1p-Ran-GTP-tRNA complex must be targeted to the nuclear pores and subsequently translocated into the cytoplasm. Targeting to the pores and translocation could be achieved through the interaction of Los1p with nucleoporins (see below), but in general these steps are the least understood in the nuclear transport process. Finally, once in the cytoplasmic environment, the export complex may be dissociated by RanBP1 followed by RanGAP-induced hydrolysis of Ran-bound GTP. Indeed, we have shown that Yrb1p (the yeast RanBP1) inhibits the tRNA-induced association of Los1p with Ran-GTP, and a similar effect has also been shown for importin  and CAS (57) and for the human homologue of Los1p (59). The dissociation of Los1p from Ran would trigger the release of tRNA. However, it is very likely that tRNA is not set free to diffuse in the cytosol but is instead directly delivered to cytoplasmic tRNA-binding proteins, such as Arc1p and Gcd11p, that would guide it through the subsequent steps, tRNA aminoacylation and delivery to the ribosome.

Surprisingly, we have also found in the two-hybrid screen a potential interaction between Los1p and the translation initiation factor eIF-2 (Gcd11p), specifically with its carboxy-terminal domain, which is thought to mediate the binding of eIF-2 to tRNA (15). Since we were not able to copurify eIF-2 with Los1p, the two-hybrid interaction could be indirect, through a tRNA molecule that bridges eIF-2 with the tRNA-binding domain in Los1p. On the other hand, we have found that certain point mutations in the carboxy-terminal domain of eIF-2 cause synthetic lethality when combined with the los1 disruption mutant; i.e., Los1p and Gcd11p also functionally interact. Independent of a direct or indirect interaction of eIF-2 with Los1p, high-affinity binding sites for tRNA in the cytoplasm may ensure its efficient and direct transfer from Los1p to the protein translation machinery in a channeling mode, without the involvement of free diffusion (66, 99). It has recently been shown that tRNA aminoacylation can also occur inside the nucleus and may be required for nuclear export of tRNA in Xenopus oocytes (61a). If this is also the case in yeast, the interaction of Los1p with eIF-2 may occur inside the nucleus as part of the delivery of the aminoacylated tRNA to the nuclear export machinery.

Binding to and translocation through the nuclear pore complexes are necessary intermediate steps for all reactions involving transport between the nucleus and cytoplasm. We have demonstrated an interaction of Los1p with Nup2p both in the two-hybrid system and biochemically. We have also shown biochemically that Los1p interacts with Nsp1p, to which it is also genetically linked. The fact that we did not find Nsp1p in the two-hybrid screen probably indicates that the interaction domains involved are sensitive to the orientational or conformational changes that result from the fusion of the proteins to GAL activation or DNA binding sequences. Direct binding to the FXFG or GLFG nucleoporin repeat sequences has been previously reported for members of the importin/karyopherin--like protein family (1, 47, 74-76, 79). Although Nsp1p is genetically and physically linked to many other nucleoporins (36-38, 104), it has never been found in genetic screens to be linked to soluble transport factors, with the exception of Los1p. Therefore, the physical and genetic interactions between Nsp1p and Los1p (94), as well as the genetic interaction between Nsp1p and Arc1p (92), suggest that Nsp1p (most likely in one of its different subcomplexes) is involved in tRNA export through the nuclear pores. Since Nsp1p has recently been localized on both sides of the central gated channel of the NPC (18), it is possible that Nsp1p (or one of its different subcomplexes) is involved in tRNA export. The role of Nup2p in nucleocytoplasmic transport is less-well studied. Nup2p is not essential in yeast, but it is required for viability of strains carrying mutations in nucleoporin Nsp1p or Nup1p, with which Nup2p is homologous, in the central FXFG repeat-containing domain (61). Interestingly, Nup2p shares a redundant function with the other two FXFG repeat sequence-containing nucleoporins, Nup1p and Nsp1p (61). Therefore, all of these nucleoporins could provide docking sites for Los1p at the NPC or facilitate translocation through the NPC.

The converging of several transport pathways at the NPC, where soluble receptors encounter the same group of nucleoporins, could explain the dominant-negative phenotype of LOS1 overexpression. Dominant-negative phenotypes have been reported previously in the case of importin  and yeast Yrb4p mutants which caused inhibition of both nuclear import and export pathways (58, 83). Overexpression of LOS1 or LOS1N, however, predominantly affects nuclear export processes, as shown for mRNA export, and causes intranuclear accumulation of Yrb1p and Mex67p. Therefore, an excess of Los1p may saturate sites at the NPC that are preferentially involved in nuclear export. Alternatively, excess Los1p may bind to and inactivate another transport factor, such as Gsp1p, which is required for both nuclear import and export. This could explain why overproduction of Los1p also affects slightly the nuclear import of Npl3p and Pus1p. On the other hand, overproduction of Los1Np, which lacks the putative Gsp1p-binding domain but can still interact with nucleoporins, has no effect on nuclear import and causes a stronger RNA export defect, suggesting that in this case the defect is due to unproductive binding of Los1Np to NPC sites also used by other nuclear export factors.

What remains puzzling is that LOS1 is not required for cell growth. On the other hand, Los1p's function becomes essential if upstream or downstream steps in tRNA biogenesis are affected; e.g., the synthesis rate of tRNA is reduced by mutating the tRNA transcription factor Tfc4p, intranuclear tRNA modification is inhibited by mutating Pus1p, aminoacylation is slowed down by mutating Arc1p (92-94), or delivery of initiator tRNA^Met to the ribosomes is affected by mutating a subunit of eIF-2. It is therefore possible that all of these impairments render Los1p essential for viability because, when combined with a deficiency in tRNA nuclear export, they cause the pool of functional tRNA molecules in the cytoplasm to drop below a threshold level required to sustain cell growth. Also, the initial finding that LOS1 is a gene involved in suppressor tRNA activity (44) can be most easily explained by a requirement of Los1p for efficient export of tRNA. However, it is clear that there must be a redundant pathway(s) in the cell to compensate for a putative tRNA export defect in los1 mutants. Since there are still uncharacterized importin--like proteins in yeast, it is possible that some of them act as mediators of tRNA export as well and overlap with the Los1p function. Alternatively, there may be additional tRNA export pathways which do not require the action of importin--like transport factors.